Compromise likely as G20 unconvinced on vaccine IP waivers
G20 leaders are to commit to ‘patent-pooling’, which is a less radical measure to encourage the sharing of patents, a draft document shows
18 May 2021 - 15:30
Brussels — Leaders of the world’s largest economies back “voluntary licensing” of Covid-19 vaccine patents, the draft conclusions of a summit show, watering down a US push for waivers and earlier commitments to supply more funds to the World Health Organisation (WHO).
The draft document, seen by Reuters, lists commitments of G20 nations and other countries and is to be adopted on Friday at a Global Health Summit in Rome, one of 2021’s major events to co-ordinate global actions against the pandemic...
Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.
Please read our Comment Policy before commenting.
Subscribe now to unlock this article.
Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).
There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.
Cancel anytime.
Questions? Email helpdesk@businesslive.co.za or call 0860 52 52 00. Got a subscription voucher? Redeem it now.